Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity.

When Page Campbell’s doctor recommended she try an injectable prescription drug called Wegovy to lose weight before scheduling bariatric surgery, she readily agreed.

Experts highlight the complex mix of genetics, biology and environment in obesity. Study shows fat cells' memory affects metabolism and weight management.

Carrying extra pounds on your body can put you at risk of diabetes, high blood pressure, heart disease, and even cancer.

Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to newly released FAIR ...

By the third year, Woodruff knew her days of running The TRAP full-time were numbered. In March 2024, at the urging of Pike ...

Dr. Laura Guadiana Sanchez, a physician with SGMC Health since 2017, has transitioned from family medicine to specialize in ...

TxtSquad, an AI-powered patient engagement platform, is expanding its impact through a new partnership with the Coordinated ...

TruSkin’s newest launch, the SPF Serum, is getting rave reviews—4.8 stars on Amazon—and it’s easy to see why. As Dr. Marisa Garshick, a board-certified dermatologist, explains “It offers SPF 30 ...

Sleep apnea may lead to weight gain by disrupting sleep, affecting hunger hormones, slowing metabolism, and more. Lifestyle ...

A recent survey by the ECA-APER and the Poddar Institute of Education has laid bare some alarming truths: 45 percent of Indian children today are overweight, and a staggering 67 percent spend less ...

In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.  Fair Health ...